ID:1882 Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3

Giovanni Selvaggi, Heather A. Wakelee, Tony Mok, Yi‐Long Wu, Martin Reck, Alberto Chiappori, I. Cicin, Daniel Lee, В. В. Бредер, Yun Fan, С. В. Орлов, Elena Poddubskaya, Z. Wang, Ying Cheng, Y. Liu, Gang Wu, Li Mao, Jinjin Zhou, V. Oertel, Leora Horn, Chun-Ling Liang